Skip to main content
VCbacked
Log inGet Started

SeLux Diagnostics

Charlestown, United States

SeLux Diagnostics is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients.

$48.0M raised
Apr 2024
Series D
BiotechnologyHealth CareHealth DiagnosticsTherapeutics

Top Investors

RA Capital ManagementSands Capital VenturesNational Institutes of HealthNorthpond VenturesSchooner Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about SeLux Diagnostics

How much funding has SeLux Diagnostics raised?
SeLux Diagnostics has raised $48.0M in total funding. The most recent round was Series D. The last funding was announced in April 2024.
Who are SeLux Diagnostics's investors?
SeLux Diagnostics's investors include RA Capital Management, Sands Capital Ventures, National Institutes of Health, Northpond Ventures, Schooner Capital.
Where is SeLux Diagnostics headquartered?
SeLux Diagnostics is headquartered in Charlestown, United States.
What does SeLux Diagnostics do?
SeLux Diagnostics is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients.
What stage is SeLux Diagnostics at?
SeLux Diagnostics is at the Series D stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"SeLux Diagnostics — Funding & Investors." VCBacked, April 1, 2024, https://www.vcbacked.co/company/selux-diagnostics. Accessed June 4, 2026.
APA
VCBacked. (2024). SeLux Diagnostics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/selux-diagnostics
Wikipedia (cite web)
{{cite web |title=SeLux Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/selux-diagnostics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong